Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness
NCT: NCT07716384 · NOT_YET_RECRUITING
Brief Summary
Liver stiffness measurement is a key non-invasive tool for assessing liver fibrosis and cirrhosis in patients with chronic liver disease. Transient elastography (FibroScan) is currently the most widely used non-invasive reference standard, but it requires a dedicated device and trained operator, which may limit its accessibility in some clinical settings. This study aims to evaluate the diagnostic accuracy of a novel wearable patch-type ultrasound probe for detecting significant liver fibrosis and cirrhosis, using FibroScan as the reference standard. Patients with chronic liver disease will undergo simultaneous liver stiffness measurement using both the wearable patch ultrasound probe and FibroScan. The diagnostic performance of the patch probe, including sensitivity, specificity, and area under the receiver operating characteristic curve (AUC), will be evaluated against fibrosis staging determined by FibroScan, along with the correlation and agreement between the two measurement methods.
Frequently Asked Questions
What is Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness?
Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness is a clinical trial registered under NCT07716384. Current status: NOT_YET_RECRUITING.
What is the status of NCT07716384?
The current status of NCT07716384 (Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness) is: NOT_YET_RECRUITING.
When did Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness start?
Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness started on 2026-10-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.